The Patent Finder

Proter S.P.A.

Also on record
Records under this name other than the patents Proter S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Proter S.P.A.

PatentTitleStatus Expires Confidence
US 4,216,208N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
Term ended
Term ended no later than Aug 5, 2000 · Low confidence
Term endedTerm ended no later than Aug 5, 2000Low confidence
US 4,244,968Treatment of arthritis and substances for use in such treatment
Term ended
Term ended no later than Jan 13, 2001 · Low confidence
Term endedTerm ended no later than Jan 13, 2001Low confidence
US 4,314,999N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity
Term ended
Term ended no later than Feb 9, 2002 · Low confidence
Term endedTerm ended no later than Feb 9, 2002Low confidence
US 4,428,875Compounds of dichlorodiethylaminophenylalanine with anti-tumor activity
Term ended
Term ended no later than Jan 31, 2004 · Low confidence
Term endedTerm ended no later than Jan 31, 2004Low confidence
US 4,485,248Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxyethoxy-benzyl)-pyrimidine
Term ended
Term ended no later than Nov 27, 2004 · Low confidence
Term endedTerm ended no later than Nov 27, 2004Low confidence
US 4,508,710In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
Formerly held
Term ended
Term ended no later than Apr 2, 2005 · Low confidence
Term endedTerm ended no later than Apr 2, 2005Low confidence
US 4,540,683In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
Term ended
Term ended no later than Sep 10, 2005 · Low confidence
Term endedTerm ended no later than Sep 10, 2005Low confidence
US 4,666,887Intravenous or intraperitoneal administration of a tripeptide compound for treating cancer
Term ended
Term ended no later than May 19, 2007 · Low confidence
Term endedTerm ended no later than May 19, 2007Low confidence
US 4,740,501Interference of b-type retrovirus replication with a tripeptide compound
Term ended
Term ended no later than Apr 26, 2008 · Low confidence
Term endedTerm ended no later than Apr 26, 2008Low confidence
US 4,861,599Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use
Formerly held
Term ended
Term ended no later than Aug 29, 2009 · Low confidence
Term endedTerm ended no later than Aug 29, 2009Low confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited